Recruiting Heart Attack Studies in Saint Paul
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE...
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
This is a sub-study of Study RM-493-040 (NCT05774756). The goal of this sub-study is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years...
About Heart Attack Clinical Trials in Saint Paul
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Saint Paul, MN. These studies are seeking a combined 139 participants. Research is being sponsored by AstraZeneca, Rhythm Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Saint Paul — FAQ
Are there heart attack clinical trials in Saint Paul?
Yes, there are 2 heart attack clinical trials currently recruiting in Saint Paul, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Saint Paul?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Saint Paul research site will contact you about next steps.
Are clinical trials in Saint Paul free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Saint Paul studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Saint Paul are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov